<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2020-10-07" version="206">
<accession>O00459</accession>
<accession>Q5EAT5</accession>
<accession>Q9UPH9</accession>
<name>P85B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 3-kinase regulatory subunit beta</fullName>
<shortName>PI3-kinase regulatory subunit beta</shortName>
<shortName>PI3K regulatory subunit beta</shortName>
<shortName>PtdIns-3-kinase regulatory subunit beta</shortName>
</recommendedName>
<alternativeName>
<fullName>Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta</fullName>
<shortName>PI3-kinase subunit p85-beta</shortName>
<shortName>PtdIns-3-kinase regulatory subunit p85-beta</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PIK3R2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Oncogene" volume="7" first="789" last="793">
<title>Chromosomal localization of human p85 alpha, a subunit of phosphatidylinositol 3-kinase, and its homologue p85 beta.</title>
<authorList>
<person name="Volinia S."/>
<person name="Patracchini P."/>
<person name="Otsu M."/>
<person name="Hiles I."/>
<person name="Gout I."/>
<person name="Calzolari E."/>
<person name="Bernardi F."/>
<person name="Rooke L."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="1314371"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ARG-234 AND PRO-313</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Oncogene" volume="16" first="1767" last="1772">
<title>An oncogenic fusion product of the phosphatidylinositol 3-kinase p85beta subunit and HUMORF8, a putative deubiquitinating enzyme.</title>
<authorList>
<person name="Janssen J.W.G."/>
<person name="Schleithhoff L."/>
<person name="Bartram C.R."/>
<person name="Schulz A.S."/>
</authorList>
<dbReference type="PubMed" id="9582025"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201695"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS ARG-234 AND PRO-313</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS ARG-234 AND PRO-313</scope>
<source>
<tissue>Brain</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="2619" last="2631">
<title>Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site.</title>
<authorList>
<person name="Braunger J."/>
<person name="Schleithoff L."/>
<person name="Schulz A.S."/>
<person name="Kessler H."/>
<person name="Lammers R."/>
<person name="Ullrich A."/>
<person name="Bartram C.R."/>
<person name="Janssen J.W."/>
</authorList>
<dbReference type="PubMed" id="9178760"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201123"/>
</citation>
<scope>INTERACTION WITH AXL</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="246" first="95" last="99">
<title>Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.</title>
<authorList>
<person name="Igarashi K."/>
<person name="Isohara T."/>
<person name="Kato T."/>
<person name="Shigeta K."/>
<person name="Yamano T."/>
<person name="Uno I."/>
</authorList>
<dbReference type="PubMed" id="9600074"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8578"/>
</citation>
<scope>INTERACTION WITH FLT1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="27088" last="27097">
<title>Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress.</title>
<authorList>
<person name="Wang J.F."/>
<person name="Zhang X."/>
<person name="Groopman J.E."/>
</authorList>
<dbReference type="PubMed" id="15102829"/>
<dbReference type="DOI" id="10.1074/jbc.m314015200"/>
</citation>
<scope>INTERACTION WITH FLT4</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Biochem. J." volume="413" first="193" last="200">
<title>The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase.</title>
<authorList>
<person name="Tsuboi N."/>
<person name="Utsunomiya T."/>
<person name="Roberts R.L."/>
<person name="Ito H."/>
<person name="Takahashi K."/>
<person name="Noda M."/>
<person name="Takahashi T."/>
</authorList>
<dbReference type="PubMed" id="18348712"/>
<dbReference type="DOI" id="10.1042/bj20071317"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPRJ</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-605</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-464</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-464</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="Nat. Cell Biol." volume="15" first="472" last="480">
<title>FBXL2- and PTPL1-mediated degradation of p110-free p85beta regulatory subunit controls the PI(3)K signalling cascade.</title>
<authorList>
<person name="Kuchay S."/>
<person name="Duan S."/>
<person name="Schenkein E."/>
<person name="Peschiaroli A."/>
<person name="Saraf A."/>
<person name="Florens L."/>
<person name="Washburn M.P."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="23604317"/>
<dbReference type="DOI" id="10.1038/ncb2731"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBXL2 AND PTPN13</scope>
<scope>PHOSPHORYLATION AT TYR-655</scope>
<scope>DEPHOSPHORYLATION AT TYR-655 BY PTPN13</scope>
<scope>UBIQUITINATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF GLN-651; ARG-652 AND TYR-655</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="Clin. Genet." volume="85" first="396" last="398">
<title>AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH.</title>
<authorList>
<person name="Nakamura K."/>
<person name="Kato M."/>
<person name="Tohyama J."/>
<person name="Shiohama T."/>
<person name="Hayasaka K."/>
<person name="Nishiyama K."/>
<person name="Kodera H."/>
<person name="Nakashima M."/>
<person name="Tsurusaki Y."/>
<person name="Miyake N."/>
<person name="Matsumoto N."/>
<person name="Saitsu H."/>
</authorList>
<dbReference type="PubMed" id="23745724"/>
<dbReference type="DOI" id="10.1111/cge.12188"/>
</citation>
<scope>INVOLVEMENT IN MPPH1</scope>
<scope>VARIANT MPPH1 PRO-401</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="934" last="940">
<title>De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.</title>
<authorList>
<person name="Riviere J.B."/>
<person name="Mirzaa G.M."/>
<person name="O'Roak B.J."/>
<person name="Beddaoui M."/>
<person name="Alcantara D."/>
<person name="Conway R.L."/>
<person name="St-Onge J."/>
<person name="Schwartzentruber J.A."/>
<person name="Gripp K.W."/>
<person name="Nikkel S.M."/>
<person name="Worthylake T."/>
<person name="Sullivan C.T."/>
<person name="Ward T.R."/>
<person name="Butler H.E."/>
<person name="Kramer N.A."/>
<person name="Albrecht B."/>
<person name="Armour C.M."/>
<person name="Armstrong L."/>
<person name="Caluseriu O."/>
<person name="Cytrynbaum C."/>
<person name="Drolet B.A."/>
<person name="Innes A.M."/>
<person name="Lauzon J.L."/>
<person name="Lin A.E."/>
<person name="Mancini G.M."/>
<person name="Meschino W.S."/>
<person name="Reggin J.D."/>
<person name="Saggar A.K."/>
<person name="Lerman-Sagie T."/>
<person name="Uyanik G."/>
<person name="Weksberg R."/>
<person name="Zirn B."/>
<person name="Beaulieu C.L."/>
<person name="Majewski J."/>
<person name="Bulman D.E."/>
<person name="O'Driscoll M."/>
<person name="Shendure J."/>
<person name="Graham J.M. Jr."/>
<person name="Boycott K.M."/>
<person name="Dobyns W.B."/>
</authorList>
<dbReference type="PubMed" id="22729224"/>
<dbReference type="DOI" id="10.1038/ng.2331"/>
</citation>
<scope>INVOLVEMENT IN MPPH1</scope>
<scope>VARIANT MPPH1 ARG-373</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2017" name="Oncotarget" volume="8" first="54913" last="54924">
<title>Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK.</title>
<authorList>
<person name="Lu Y."/>
<person name="Zheng X."/>
<person name="Hu W."/>
<person name="Bian S."/>
<person name="Zhang Z."/>
<person name="Tao D."/>
<person name="Liu Y."/>
<person name="Ma Y."/>
</authorList>
<dbReference type="PubMed" id="28903391"/>
<dbReference type="DOI" id="10.18632/oncotarget.18973"/>
</citation>
<scope>INTERACTION WITH SRC</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Lancet Neurol." volume="14" first="1182" last="1195">
<title>Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.</title>
<authorList>
<person name="Mirzaa G.M."/>
<person name="Conti V."/>
<person name="Timms A.E."/>
<person name="Smyser C.D."/>
<person name="Ahmed S."/>
<person name="Carter M."/>
<person name="Barnett S."/>
<person name="Hufnagel R.B."/>
<person name="Goldstein A."/>
<person name="Narumi-Kishimoto Y."/>
<person name="Olds C."/>
<person name="Collins S."/>
<person name="Johnston K."/>
<person name="Deleuze J.F."/>
<person name="Nitschke P."/>
<person name="Friend K."/>
<person name="Harris C."/>
<person name="Goetsch A."/>
<person name="Martin B."/>
<person name="Boyle E.A."/>
<person name="Parrini E."/>
<person name="Mei D."/>
<person name="Tattini L."/>
<person name="Slavotinek A."/>
<person name="Blair E."/>
<person name="Barnett C."/>
<person name="Shendure J."/>
<person name="Chelly J."/>
<person name="Dobyns W.B."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="26520804"/>
<dbReference type="DOI" id="10.1016/s1474-4422(15)00278-1"/>
</citation>
<scope>VARIANTS MPPH1 ARG-373 AND GLU-376</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2016" name="Eur. J. Hum. Genet." volume="24" first="1359" last="1362">
<title>De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia.</title>
<authorList>
<person name="Terrone G."/>
<person name="Voisin N."/>
<person name="Abdullah Alfaiz A."/>
<person name="Cappuccio G."/>
<person name="Vitiello G."/>
<person name="Guex N."/>
<person name="D'Amico A."/>
<person name="James Barkovich A."/>
<person name="Brunetti-Pierri N."/>
<person name="Del Giudice E."/>
<person name="Reymond A."/>
</authorList>
<dbReference type="PubMed" id="26860062"/>
<dbReference type="DOI" id="10.1038/ejhg.2016.7"/>
</citation>
<scope>VARIANT MPPH1 HIS-557</scope>
</reference>
<comment type="function">
<text evidence="7 16">Regulatory subunit of phosphoinositide-3-kinase (PI3K), a kinase that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Binds to activated (phosphorylated) protein-tyrosine kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Indirectly regulates autophagy (PubMed:23604317). Promotes nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="7 12 16 20 21 23">Heterodimer of a regulatory subunit PIK3R2 and a p110 catalytic subunit (PIK3CA, PIK3CB or PIK3CD) (PubMed:23604317). Interacts with AXL (PubMed:9178760). Interacts with FLT1 (tyrosine-phosphorylated) and FLT4 (tyrosine-phosphorylated) (PubMed:9600074, PubMed:15102829). Interacts with NYAP1, NYAP2 and MYO16 (By similarity). Interacts with FBXL2; PIK3R2 is a substrate of the SCF(FBXL2) complex (PubMed:23604317). Interacts with PTPN13; dephosphorylates PIK3R2 (PubMed:23604317). Interacts with XBP1 isoform 2; the interaction is direct and induces translocation of XBP1 isoform 2 into the nucleus in a ER stress- and/or insulin-dependent but PI3K-independent manner (By similarity). Interacts with PIK3R1; the interaction is dissociated in an insulin-dependent manner (By similarity). Interacts with SRC (PubMed:28903391).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-740680">
<id>Q8WWB3</id>
<label>DYDC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>23</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-618309">
<id>Q08379</id>
<label>GOLGA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-747204">
<id>Q9UKT9</id>
<label>IKZF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-739566">
<id>P19012</id>
<label>KRT15</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-742094">
<id>P35900</id>
<label>KRT20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-1047263">
<id>O76015</id>
<label>KRT38</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-748896">
<id>Q96HT8</id>
<label>MRFAP1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-2609540">
<id>P42338</id>
<label>PIK3CB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-726876">
<id>Q6NUQ1</id>
<label>RINT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-740098">
<id>P36406</id>
<label>TRIM23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-2547442">
<id>P03496</id>
<label>NS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346930">
<id>O00459</id>
</interactant>
<interactant intactId="EBI-6149498">
<id>Q82506</id>
<label>NS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="domain">
<text evidence="16">The SH2 2 domain is required for interaction with FBXL2 and PTPN13.</text>
</comment>
<comment type="PTM">
<text evidence="14 16">Phosphorylated in response to signaling from activated receptor-type protein kinases (PubMed:19690332, PubMed:20068231). Dephosphorylated by PTPRJ (PubMed:18348712). Dephosphorylated at Tyr-655 by PTPN13. Phosphorylation of Tyr-655 impairs while its dephosphorylation promotes interaction with FBXL2 and SCF(FBXL2)-mediated polyubiquitination (PubMed:23604317).</text>
</comment>
<comment type="PTM">
<text evidence="24">Ubiquitinated. Polyubiquitination by the SCF(FBXL2) complex probably promotes proteasomal degradation of PIK3R2.</text>
</comment>
<comment type="disease" evidence="15 17 18 19">
<disease id="DI-03625">
<name>Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1</name>
<acronym>MPPH1</acronym>
<description>A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome.</description>
<dbReference type="MIM" id="603387"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the PI3K p85 subunit family.</text>
</comment>
<dbReference type="EMBL" id="X80907">
<property type="protein sequence ID" value="CAA56868.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007192">
<property type="protein sequence ID" value="AAD22671.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC070082">
<property type="protein sequence ID" value="AAH70082.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC090249">
<property type="protein sequence ID" value="AAH90249.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12371.1"/>
<dbReference type="PIR" id="H59435">
<property type="entry name" value="H59435"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005018.1">
<property type="nucleotide sequence ID" value="NM_005027.3"/>
</dbReference>
<dbReference type="PDB" id="2KT1">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-80"/>
</dbReference>
<dbReference type="PDB" id="2XS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A=108-298"/>
</dbReference>
<dbReference type="PDB" id="3MTT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=433-610"/>
</dbReference>
<dbReference type="PDB" id="3O5Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A/B=1-85"/>
</dbReference>
<dbReference type="PDB" id="6OX7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="C/D=435-597"/>
</dbReference>
<dbReference type="PDB" id="6U28">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="C/D=435-597"/>
</dbReference>
<dbReference type="PDBsum" id="2KT1"/>
<dbReference type="PDBsum" id="2XS6"/>
<dbReference type="PDBsum" id="3MTT"/>
<dbReference type="PDBsum" id="3O5Z"/>
<dbReference type="PDBsum" id="6OX7"/>
<dbReference type="PDBsum" id="6U28"/>
<dbReference type="BMRB" id="O00459"/>
<dbReference type="SMR" id="O00459"/>
<dbReference type="BioGRID" id="111314">
<property type="interactions" value="135"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1917">
<property type="entry name" value="Phosphatidylinositol 3-kinase complex class I, variant 1"/>
</dbReference>
<dbReference type="DIP" id="DIP-31811N"/>
<dbReference type="IntAct" id="O00459">
<property type="interactions" value="90"/>
</dbReference>
<dbReference type="MINT" id="O00459"/>
<dbReference type="STRING" id="9606.ENSP00000222254"/>
<dbReference type="BindingDB" id="O00459"/>
<dbReference type="ChEMBL" id="CHEMBL4437"/>
<dbReference type="DrugBank" id="DB01064">
<property type="generic name" value="Isoprenaline"/>
</dbReference>
<dbReference type="DrugBank" id="DB05210">
<property type="generic name" value="SF1126"/>
</dbReference>
<dbReference type="iPTMnet" id="O00459"/>
<dbReference type="PhosphoSitePlus" id="O00459"/>
<dbReference type="BioMuta" id="PIK3R2"/>
<dbReference type="CPTAC" id="CPTAC-1538"/>
<dbReference type="EPD" id="O00459"/>
<dbReference type="jPOST" id="O00459"/>
<dbReference type="MassIVE" id="O00459"/>
<dbReference type="MaxQB" id="O00459"/>
<dbReference type="PaxDb" id="O00459"/>
<dbReference type="PeptideAtlas" id="O00459"/>
<dbReference type="PRIDE" id="O00459"/>
<dbReference type="ProteomicsDB" id="47910"/>
<dbReference type="ABCD" id="O00459">
<property type="antibodies" value="6 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="14986">
<property type="antibodies" value="603 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000222254">
<property type="protein sequence ID" value="ENSP00000222254"/>
<property type="gene ID" value="ENSG00000105647"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000617130">
<property type="protein sequence ID" value="ENSP00000477864"/>
<property type="gene ID" value="ENSG00000105647"/>
</dbReference>
<dbReference type="GeneID" id="5296"/>
<dbReference type="KEGG" id="hsa:5296"/>
<dbReference type="UCSC" id="uc002nia.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5296"/>
<dbReference type="DisGeNET" id="5296"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000105647.14"/>
<dbReference type="GeneCards" id="PIK3R2"/>
<dbReference type="GeneReviews" id="PIK3R2"/>
<dbReference type="HGNC" id="HGNC:8980">
<property type="gene designation" value="PIK3R2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000105647">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="PIK3R2"/>
<dbReference type="MIM" id="603157">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="603387">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00459"/>
<dbReference type="OpenTargets" id="ENSG00000105647"/>
<dbReference type="OpenTargets" id="ENSG00000268173"/>
<dbReference type="Orphanet" id="83473">
<property type="disease" value="Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33313"/>
<dbReference type="eggNOG" id="KOG4637">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157050"/>
<dbReference type="HOGENOM" id="CLU_007031_1_0_1"/>
<dbReference type="InParanoid" id="O00459"/>
<dbReference type="KO" id="K02649"/>
<dbReference type="OMA" id="ESNSLHP"/>
<dbReference type="OrthoDB" id="737926at2759"/>
<dbReference type="PhylomeDB" id="O00459"/>
<dbReference type="TreeFam" id="TF102033"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000105647-MONOMER"/>
<dbReference type="PathwayCommons" id="O00459"/>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112399">
<property type="pathway name" value="IRS-mediated signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1266695">
<property type="pathway name" value="Interleukin-7 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194840">
<property type="pathway name" value="Rho GTPase cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198203">
<property type="pathway name" value="PI3K/AKT activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029485">
<property type="pathway name" value="Role of phospholipids in phagocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210993">
<property type="pathway name" value="Tie2 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2424491">
<property type="pathway name" value="DAP12 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2730905">
<property type="pathway name" value="Role of LAT2/NTAL/LAB on calcium mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-373753">
<property type="pathway name" value="Nephrin family interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-388841">
<property type="pathway name" value="Costimulation by the CD28 family"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389357">
<property type="pathway name" value="CD28 dependent PI3K/Akt signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416476">
<property type="pathway name" value="G alpha (q) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, Interleukin-5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9009391">
<property type="pathway name" value="Extra-nuclear estrogen signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912526">
<property type="pathway name" value="Interleukin receptor SHC signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912631">
<property type="pathway name" value="Regulation of signaling by CBL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673767">
<property type="pathway name" value="Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673770">
<property type="pathway name" value="Signaling by PDGFRA extracellular domain mutants"/>
</dbReference>
<dbReference type="SignaLink" id="O00459"/>
<dbReference type="SIGNOR" id="O00459"/>
<dbReference type="BioGRID-ORCS" id="5296">
<property type="hits" value="49 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PIK3R2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O00459"/>
<dbReference type="GeneWiki" id="PIK3R2"/>
<dbReference type="GenomeRNAi" id="5296"/>
<dbReference type="Pharos" id="O00459">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O00459"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="O00459">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000105647">
<property type="expression patterns" value="Expressed in temporal lobe and 118 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O00459">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O00459">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005942">
<property type="term" value="C:phosphatidylinositol 3-kinase complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046935">
<property type="term" value="F:1-phosphatidylinositol-3-kinase regulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030971">
<property type="term" value="F:receptor tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001678">
<property type="term" value="P:cellular glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043409">
<property type="term" value="P:negative regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046854">
<property type="term" value="P:phosphatidylinositol phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043551">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051056">
<property type="term" value="P:regulation of small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034976">
<property type="term" value="P:response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd09930">
<property type="entry name" value="SH2_cSH2_p85_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd09942">
<property type="entry name" value="SH2_nSH2_p85_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd11909">
<property type="entry name" value="SH3_PI3K_p85beta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.555.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR032498">
<property type="entry name" value="PI3K_P85_iSH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR035586">
<property type="entry name" value="PI3K_p85beta_SH3"/>
</dbReference>
<dbReference type="InterPro" id="IPR035020">
<property type="entry name" value="PI3kinase_P85_cSH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR035022">
<property type="entry name" value="PI3kinase_P85_nSH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR008936">
<property type="entry name" value="Rho_GTPase_activation_prot"/>
</dbReference>
<dbReference type="InterPro" id="IPR000198">
<property type="entry name" value="RhoGAP_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="Pfam" id="PF16454">
<property type="entry name" value="PI3K_P85_iSH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00620">
<property type="entry name" value="RhoGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00324">
<property type="entry name" value="RhoGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48350">
<property type="entry name" value="SSF48350"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50238">
<property type="entry name" value="RHOGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Phosphatidylinositol 3-kinase regulatory subunit beta" id="PRO_0000080763">
<location>
<begin position="1"/>
<end position="728"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="10">
<location>
<begin position="4"/>
<end position="80"/>
</location>
</feature>
<feature type="domain" description="Rho-GAP" evidence="8">
<location>
<begin position="109"/>
<end position="295"/>
</location>
</feature>
<feature type="domain" description="SH2 1" evidence="9">
<location>
<begin position="330"/>
<end position="425"/>
</location>
</feature>
<feature type="domain" description="SH2 2" evidence="9">
<location>
<begin position="622"/>
<end position="716"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5 6">
<location>
<position position="464"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="605"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="16">
<location>
<position position="655"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2241088." id="VAR_030679" evidence="11 13 22">
<original>S</original>
<variation>R</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1011320." id="VAR_030680" evidence="11 13 22">
<original>S</original>
<variation>P</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH1; dbSNP:rs587776934." id="VAR_069262" evidence="15 18">
<original>G</original>
<variation>R</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH1; unknown pathological significance; dbSNP:rs886041591." id="VAR_075556" evidence="18">
<original>K</original>
<variation>E</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH1; dbSNP:rs587777624." id="VAR_075683" evidence="17">
<original>L</original>
<variation>P</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH1; dbSNP:rs372272045." id="VAR_075684" evidence="19">
<original>D</original>
<variation>H</variation>
<location>
<position position="557"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with FBXL2 and increased half-life; when associated with A-652." evidence="16">
<original>Q</original>
<variation>A</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with FBXL2 and increased half-life; when associated with A-651." evidence="16">
<original>R</original>
<variation>A</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="mutagenesis site" description="Stabilized interaction with FBXL2 and decreased half-life." evidence="16">
<original>Y</original>
<variation>A</variation>
<location>
<position position="655"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="5"/>
<end position="11"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="30"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="47"/>
<end position="49"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="56"/>
<end position="61"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="75"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="114"/>
<end position="117"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="167"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="188"/>
<end position="199"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="206"/>
<end position="209"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="211"/>
<end position="213"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="216"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="239"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="279"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="435"/>
<end position="492"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="523"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="535"/>
<end position="561"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="564"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="588"/>
<end position="594"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2XS6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3O5Z"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6OX7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O08908"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00172"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1314371"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15102829"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18348712"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22729224"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23604317"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23745724"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26520804"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26860062"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28903391"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9178760"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9582025"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9600074"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="23604317"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="728" mass="81545" checksum="ADAC3E4B61F3F44A" modified="2011-01-11" version="2">MAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGLNERTRQRGDFPGTYVEFLGPVALARPGPRPRGPRPLPARPRDGAPEPGLTLPDLPEQFSPPDVAPPLLVKLVEAIERTGLDSESHYRPELPAPRTDWSLSDVDQWDTAALADGIKSFLLALPAPLVTPEASAEARRALREAAGPVGPALEPPTLPLHRALTLRFLLQHLGRVASRAPALGPAVRALGATFGPLLLRAPPPPSSPPPGGAPDGSEPSPDFPALLVEKLLQEHLEEQEVAPPALPPKPPKAKPASTVLANGGSPPSLQDAEWYWGDISREEVNEKLRDTPDGTFLVRDASSKIQGEYTLTLRKGGNNKLIKVFHRDGHYGFSEPLTFCSVVDLINHYRHESLAQYNAKLDTRLLYPVSKYQQDQIVKEDSVEAVGAQLKVYHQQYQDKSREYDQLYEEYTRTSQELQMKRTAIEAFNETIKIFEEQGQTQEKCSKEYLERFRREGNEKEMQRILLNSERLKSRIAEIHESRTKLEQQLRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLGIKNETEDQYALMEDEDDLPHHEERTWYVGKINRTQAEEMLSGKRDGTFLIRESSQRGCYACSVVVDGDTKHCVIYRTATGFGFAEPYNLYGSLKELVLHYQHASLVQHNDALTVTLAHPVRAPGPGPPPAAR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

